US Earnings Financial Results SEC Filings — May 11, 2026

11-05-2026

Townsquare Media reported Q1 2026 net revenue of $96.8M, down 1.9% YoY from $98.7M, driven by declines in Broadcast Advertising (-6.6%), Subscription Digital Marketing Solutions (-7.9%), and Other (-10.3%), though Digital Advertising grew 6.9% to $39.3M. Operating loss widened to $1.3M from $7.1M income due to an $8.6M intangible impairment and higher expenses, but net income turned positive at $3.0M (vs. $1.5M loss) largely from a $15.7M tax benefit. Cash from operations improved sharply to $4.2M from a $66K use, while total cash and equivalents fell to $2.2M from $4.8M at year-end.

• · Dividends declared at $0.20 per share, totaling $3.967M.
• · Stockholders’ deficit improved to $(36.2M) from $(41.0M) at year-end.
• · Accounts receivable decreased to $49.1M from $52.0M QoQ.
• · Interest expense increased to $11.3M from $10.2M YoY.
• · Weighted average basic shares outstanding: 16,800K (up from 15,887K YoY).

11-05-2026

Dole plc reported Q1 2026 net revenues of $2.34B, up 11.6% YoY from $2.10B, with strong growth in diversified produce (+15.0% to $1.40B) and tropical fruit (+6.1% to $827M), while commercial cargo declined 5.5% to $45M. However, operating income fell 8.7% YoY to $62M amid higher selling, marketing, general and administrative expenses, and net income attributable to Dole plc decreased 19.5% to $31M with EPS of $0.33. Total assets grew slightly to $4.45B as of March 31, 2026, and cash & equivalents rose to $273M.

• · Net cash used in operating activities from continuing operations improved to -$22.5M from -$78.8M YoY.
• · Long-term debt increased to $870M from $800M QoQ.
• · Dividends paid to shareholders: $8.6M in Q1 2026 vs $7.8M in Q1 2025.
• · Gross profit margin slightly improved to 7.9% from 8.7%? Wait, calculate: 184993/2342175≈7.90%, 182193/2099404≈8.68%, actually slight decline.

11-05-2026

Carlyle Secured Lending, Inc. reported total investment income of $64,079 (up 16.8% YoY from $54,864) and net investment income of $25,204 (up 16.5% YoY from $21,629) for the three months ended March 31, 2026. However, net realized losses of $9,618 and unrealized depreciation of $19,804 resulted in a net decrease in net assets from operations of $4,218 (vs. $14,054 increase YoY) and EPS of -$0.06 (vs. $0.25 YoY), while total investments declined 7.6% QoQ to $2,277,105 from $2,463,922 and NAV per share fell 2.2% QoQ to $15.89 from $16.26.

• · Common stock repurchases totaled $18,501 during Q1 2026.
• · Dividends declared on preferred and common stock: $28,108 in Q1 2026 (vs. $23,757 YoY).
• · Net cash provided by operating activities: $212,389 in Q1 2026 (up from $145,801 YoY).

11-05-2026

11-05-2026

For the three months ended March 31, 2026, Sino Green Land Corp. reported net revenues of $334,766, up 69% YoY from $197,940, and a reduced net loss of $306,008 compared to $485,082 prior year, while gross loss narrowed to $78,936 from $384,955. Over the nine months ended March 31, 2026, revenues grew 38% YoY to $1,060,984, with net loss improving to $718,959 from $1,177,057, though general and administrative expenses rose sharply to $201,005 in Q3 from $70,271. Total assets increased to $4,951,094 from $4,434,219 at June 30, 2025, but total liabilities climbed to $7,824,098 from $6,828,878, widening stockholders' deficit to $2,873,004.

• · Cash flows from operating activities turned positive at $64,930 for nine months ended March 31, 2026, vs $(437,751) prior year.
• · Property, plant and equipment, net increased to $4,192,283 from $4,099,211.
• · Amount due to related parties decreased to $2,868,312 from $3,262,864.
• · Proceeds from issuance of common stock: $314,700 during the period.

11-05-2026

National Energy Services Reunited Corp. (NESR) reported robust Q1 2026 financial results with revenues of $404,586 thousand, up 33.5% YoY from $303,102 thousand, gross profit of $51,831 thousand (up 38.6% YoY), operating income of $36,035 thousand (up 72.1% YoY), and net income of $23,827 thousand (up 129.3% YoY to $0.24 basic EPS). Total assets grew to $1,923,930 thousand as of March 31, 2026 from $1,851,519 thousand at year-end 2025, with equity rising to $995,209 thousand. However, cash and equivalents declined QoQ to $92,956 thousand from $124,797 thousand amid sharp increases in accounts receivable ($227,932 thousand, +28%) and unbilled revenue ($171,341 thousand, +41%), alongside net cash used in investing ($36,435 thousand) and financing ($25,301 thousand) activities.

• · Net cash provided by operating activities: $30,745 thousand in Q1 2026 (up from $20,485 thousand in Q1 2025).
• · Capital expenditures: $36,004 thousand in Q1 2026 (up from $30,124 thousand in Q1 2025).
• · Accounts payable and accrued expenses increased QoQ to $483,048 thousand from $421,064 thousand.

11-05-2026

Minerva Gold Inc. reported revenue growth of 28.8% YoY to $33,500 for the year ended February 28, 2026, driven by higher sales. However, operating expenses increased 29.5% to $42,889, leading to a widened net loss of $9,389 from $7,123 in the prior year, with cash and total assets declining sharply to $7,077 and $10,116, respectively. Stockholders' equity deficit deepened to $(50,164) from $(40,775).

• · Net cash used in operating activities increased to $10,103 from $1,390 YoY.
• · No cash flows from investing or financing activities in FY2026, compared to $3,500 used in investing and $22,070 provided by financing in FY2025.
• · Net operating loss carryforward for deferred tax assets: $18,178 (2026) vs. $16,207 (2025), fully offset by valuation allowance.

11-05-2026

For Q1 2026, OPAL Fuels reported total revenues of $73.4M, down 14% YoY from $85.4M, driven by declines in RNG fuel (-22% to $21.6M) and fuel station services (-12% to $44.6M), while renewable power was essentially flat (+0.6% to $7.2M). Operating loss widened to $4.8M from $1.9M, resulting in a net loss of $5.6M versus net income of $1.3M in Q1 2025, and Class A common stockholders' net loss increased to $2.6M from $0.2M. However, cash and equivalents surged to $133.2M from $24.4M at year-end 2025, bolstered by $116.7M in financing proceeds and positive operating cash flow of $12.9M.

• · Net cash used in investing activities Q1 2026: $19.4M, primarily due to $24.4M PPE purchases.
• · Net cash provided by financing activities Q1 2026: $115.1M, including $128.4M loan proceeds and $116.7M preferred NCI issuance net of $100M redemption.
• · Stock-based compensation expense Q1 2026: $2.1M.
• · Total liabilities increased to $548.7M from $461.7M at Dec 31, 2025.

11-05-2026

EchoStar reported Q1 2026 total revenue of $3,667,489, down 5.2% YoY from $3,869,758, with service revenue declining 6.4% to $3,375,540 while equipment sales rose 10.7% to $291,949; operating income improved sharply to $392,847 from a $88,132 loss. However, high interest expense of $592,660 led to a net loss of $147,300, improved from $203,281 YoY, and cash decreased QoQ 28.6% to $1,343,780 amid going concern doubts due to insufficient cash flows. Total assets fell to $41,375,692 from $43,016,355 QoQ.

• · Substantial doubt about going concern due to insufficient cash, projected cash flows, or committed financing for next 12 months.
• · EPS basic and diluted: $(0.51) for Q1 2026, improved from $(0.71) YoY.
• · Interest expense increased to $592,660 from $286,055 YoY.
• · Weighted-average shares outstanding: 289,014 thousand basic and diluted.

11-05-2026

Hapi Metaverse Inc. reported Q1 2026 revenue of $60,902, up 10% YoY from $55,301, driven by Food & Beverage growth, with gross profit rising 38% to $38,981 and net loss narrowing significantly to $(246,374) from $(1,543,464) due to lower operating expenses and absence of prior year's large unrealized loss. However, cash and cash equivalents declined QoQ to $418,841 from $497,189 amid $320,248 operating cash burn, total assets fell 3% to $1,540,389, and stockholders' deficit worsened slightly to $(1,731,469). The company remains heavily reliant on related party financing and notes, with ongoing net losses.

• · Operating cash burn improved 8.5% YoY to $320,248 from $350,195, supported by $183,508 advances from related parties.
• · Related party liabilities transferred to equity: $162,482.
• · Foreign currency translation adjustment contributed $63,331 to other comprehensive income.

11-05-2026

RingCentral reported Q1 2026 total revenues of $644,199 thousand, up 5.2% YoY from $612,056 thousand, with subscriptions growing 5.6% to $623,166 thousand while other revenues declined 4.1% to $21,033 thousand. The company achieved a significant turnaround with net income of $30,618 thousand versus a $10,328 thousand loss YoY, and operating income of $50,028 thousand versus $10,340 thousand, aided by a 1.6% reduction in operating expenses to $414,741 thousand. However, cash and equivalents fell to $116,578 thousand from $132,564 thousand at December 31, 2025, total assets decreased to $1,421,629 thousand from $1,481,455 thousand, and stockholders' deficit widened to $(609,322) thousand from $(588,119) thousand amid $82,365 thousand in share repurchases and debt refinancing.

• · Net cash provided by operating activities increased to $164,046 thousand from $149,662 thousand YoY.
• · Cash paid for business combination $7,929 thousand in Q1 2026.
• · Dividends declared $6,413 thousand ($0.075 per share) in Q1 2026.
• · Share-based compensation expense $48,554 thousand in Q1 2026.

11-05-2026

For Q1 2026, bioAffinity Technologies reported net revenue of $1,351,527, down 27% YoY from $1,853,597, while total operating expenses rose 11% to $4,968,503, driving a net loss of $3,630,610 versus $2,660,417 in Q1 2025. Cash and cash equivalents fell to $3,098,366 from $6,449,782 at year-end 2025, reflecting net cash used in operations of $3,227,240, more than double the prior year's burn. Stockholders' equity declined to $3,661,386 from $7,277,656 QoQ amid higher losses and accumulated deficit expansion to $72,184,674.

• · Direct costs and expenses decreased 32% YoY to $928,636 from $1,367,860.
• · Selling, general and administrative expenses increased 32% YoY to $3,241,602 from $2,452,549.
• · Clinical development expenses rose 141% YoY to $334,040 from $138,353.
• · Net cash used in operating activities increased 96% YoY to $3,227,240 from $1,641,775.

11-05-2026

Western Alliance Bancorporation reported Q1 2026 total assets of $98,853M, up 6.5% QoQ from $92,774M, driven by 7.2% deposit growth to $82,723M and net loans HFI up slightly 0.8% to $58,681M. Net interest income rose 17.8% YoY to $766.3M and non-interest income more than doubled to $252.6M; however, provision for credit losses surged to $213.2M from $31.2M YoY, leading to net income attributable to WAL declining 8.5% to $182.1M and diluted EPS falling 7.8% to $1.65. Comprehensive income attributable to WAL dropped sharply to $70.8M from $254.3M YoY amid other comprehensive losses.

• · Stock repurchases of $50.3M in Q1 2026 (0.7M shares)
• · Dividends declared per common share $0.42 in Q1 2026 vs $0.38 in Q1 2025
• · Net cash provided by financing activities $5,923.7M in Q1 2026 vs $2,430.3M in Q1 2025
• · Allowance for credit losses on loans steady at $461M QoQ

11-05-2026

Gold.com, Inc. reported explosive revenue growth of 244% YoY to $10,350,729 in the three months ended March 31, 2026, with gross profit up 331% to $176,580 and net income attributable to the company swinging to $59,487 from a prior-year loss of $8,546. Total assets more than doubled to $4,174,073, driven by sharp increases in inventories ($2,766,561) and derivative assets ($434,798), alongside acquisitions and a $117,623 private placement; nine-month revenues rose 142% to $20,508,395. However, current liabilities surged to $3,119,329 from $1,114,128, primarily due to higher deferred revenue ($1,404,036, including $362,596 from related parties) and liabilities on borrowed metals ($916,696), while interest expense increased 47% over nine months to $47,883.

• · Operating cash flow for nine months ended March 31, 2026: $153,030 vs $85,381 prior year.
• · Acquisition purchase price details: $103,280 total including $43,618 common stock; another $26,711.
• · Deferred revenue includes $362,596 from related parties as of March 31, 2026.
• · Basic EPS for Q3: $2.17 vs $(0.36) prior year.
• · Shares issued for acquisitions: 593,438 in Q3 FY26.

11-05-2026

Prosperity Bancshares Inc reported Q1 2026 total assets of $43.6B, up 13% QoQ from $38.5B, driven by acquisitions of American Bank Holding Corporation and Southwest Bancshares, Inc., with loans growing 16% to $25.3B and deposits up 15% to $32.6B. Net interest income rose 21% YoY to $321M, but net income fell 11% YoY to $116M due to $43M in merger-related expenses and higher salaries and processing costs, resulting in diluted EPS of $1.16 versus $1.37 YoY. No provision for credit losses was recorded in either period.

• · Cash and cash equivalents decreased $200M QoQ to $1.5B.
• · Allowance for credit losses on loans increased to $384M from $334M QoQ.
• · Common stock repurchases totaled $57M in Q1 2026.
• · Cash dividends declared at $0.60 per share in Q1 2026, up from $0.58 in Q1 2025.

11-05-2026

CleanCore Solutions, Inc. reported nine-month revenue growth of 113.5% YoY to $2,520,540, driven by Janitorial and Sanitation segment (+133%) and new International revenue, while total assets expanded to $73,850,229 from $8,466,821 bolstered by $49,203,118 in digital assets and $160.7M in financing inflows. However, the company posted a massive nine-month net loss of $148,531,825 versus $2,670,469 prior year, primarily due to $107,384,528 unrealized loss on digital assets and G&A expenses surging to $41,543,474; three-month revenue declined 2.6% YoY to $543,694 with a gross loss of $419,259.

• · Gross profit for three months ended March 31, 2026 was a loss of $419,259 versus profit of $311,132 YoY.
• · G&A expenses for nine months ended March 31, 2026 increased to $41,543,474 from $2,863,998 YoY.
• · Change in fair value of digital assets contributed -$107,384,528 to nine months other expense.
• · Proceeds from private placement of pre-funded warrants, net: $137,907,255.
• · Domestic revenue three months ended March 31, 2026: $268,652 (down from $557,915, now 49% of total).

11-05-2026

indie Semiconductor, Inc. reported Q1 2026 total revenue of $55,457 thousand, up 2.6% YoY from $54,077 thousand, with product revenue increasing 2.3% to $51,567 thousand and contract revenue up 6.4% to $3,890 thousand. However, the net loss widened to $47,122 thousand from $37,171 thousand YoY, driven by a $3,656 thousand loss from debt extinguishment, a $1,085 thousand loss on contingent considerations, and higher COGS (+9.0%) and SG&A (+10.6%), despite R&D expenses declining 8.5% to $38,528 thousand. Cash and equivalents rose 19.9% QoQ to $174,433 thousand, but long-term debt increased 18.6% to $402,816 thousand after $170,500 thousand in new issuances and $106,371 thousand repurchase.

• · Net cash used in operating activities improved to $22,126 thousand from $29,001 thousand YoY.
• · Purchases of property and equipment $3,212 thousand in Q1 2026.
• · Inventory increased 17.3% QoQ to $57,038 thousand, with finished goods up 76.5% to $14,532 thousand.
• · Goodwill $289,679 thousand as of March 31, 2026, down slightly from $292,644 thousand.
• · emotion3D GmbH acquisition goodwill $16,394 thousand.

11-05-2026

Udemy's Q1 2026 revenue declined 4% YoY to $191.4M from $200.3M, primarily due to a sharp 19% drop in Consumer revenue to $58.5M, though Enterprise revenue grew 4% to $132.9M. Net loss widened significantly to $12.6M from $1.8M YoY amid higher operating expenses of $141.8M (up 6%), with gross profit remaining nearly flat at $129.3M. Positively, operating cash flow rose 27% to $15.4M, boosting cash and equivalents to $252.6M.

• · Total assets increased QoQ to $634.6M from $617.7M as of Dec 31, 2025.
• · Stockholders' equity rose to $212.2M from $210.5M QoQ.
• · Purchases of strategic investments: $8.0M in Q1 2026.
• · Deferred revenue current: $299.9M as of March 31, 2026 (up from $294.1M QoQ).

11-05-2026

Galaxy Gaming, Inc. reported Q1 2026 total revenue of $7,662,561, down 1.6% YoY from $7,784,933, with Americas revenue declining 10% to $4,051,265 while EMEA rose 10% to $3,611,296. Income from operations increased 10% to $2,173,665 due to lower costs including reduced R&D and no prior-year debt extinguishment loss, driving a swing to net income of $1,367,556 from a $2,021,282 loss. Cash provided by operating activities more than doubled to $2,544,086, though total assets dipped slightly QoQ to $27,042,819.

• · Cost of ancillary products and assembled components fell to $67,188 from $188,002 YoY.
• · Research and development expenses decreased to $152,058 from $362,776 YoY.
• · No loss on extinguishment of debt in Q1 2026 vs. $2,969,585 in Q1 2025.
• · Net cash used in investing activities $1,030,320 in Q1 2026 vs. $283,330 in Q1 2025.
• · Long-term debt and liabilities, net decreased to $35,837,453 from $36,867,804 QoQ.

11-05-2026

Cannaisseur Group Inc. reported stable notes payable totaling $32,160 as of March 31, 2026, unchanged from December 31, 2025, with the Lightspeed Loan at $4,860 and EIDL at $27,300 showing no principal repayments in Q1 2026. The current portion of notes payable increased slightly to $7,531 from $7,361, while the noncurrent portion decreased marginally to $24,629 from $24,799. Interest payments on the EIDL declined to $134 in Q1 2026 from $536 in Q1 2025, reflecting flat overall debt levels.

• · Estimated useful lives for Equipment, Leasehold improvements, and Furniture and fixtures are all 3 to 5 years.
• · EIDL terms: 3.75% interest, maturity June 9, 2050, monthly payments of $134.
• · Notes payable maturity: 2027 $696; 2028 $723; 2029 $750; 2030 $779; Thereafter $21,681.
• · Revenue recognition: At point of sale in retail or upon credit card settlement for website sales.

11-05-2026

Babcock & Wilcox Enterprises reported Q1 2026 revenues of $214.4M, up 44% YoY from $148.6M, driven by higher operations, while operating loss narrowed slightly to $1.7M from $1.8M. However, net loss attributable to stockholders widened sharply to $76.9M from $22.0M, primarily due to a $70.2M non-cash loss on customer warrants fair value change, resulting in EPS of -$0.60 vs -$0.26. Operating cash flow turned positive at $17.8M from a $8.5M outflow, and cash equivalents rose to $106.5M from $89.5M at year-end.

• · Customer warrants liability increased to $142.8M as of March 31, 2026 from $8.3M at December 31, 2025.
• · Total assets grew to $757.8M from $662.9M at year-end 2025, but stockholders' deficit widened to $172.1M from $131.5M.
• · Income from discontinued operations of $2.7M in Q1 2026 vs loss of $6.4M in Q1 2025.

11-05-2026

eXp World Holdings reported Q1 2026 revenues of $1,005,541, up 5.4% YoY from $954,906, driven by higher commissions, though gross profit declined 1.0% to $75,347 from $76,135 due to elevated agent-related costs. Operating loss narrowed to $8,788 from $10,376 and net loss improved to $5,098 from $11,024, aided by lower operating expenses; however, comprehensive loss widened slightly to $6,972 amid foreign currency impacts. Balance sheet strengthened with total assets at $467,166 (up 5.6% QoQ from $442,480) and equity at $255,900 (up 5.4% QoQ).

• · Restricted cash increased to $68,210 from $57,218 QoQ.
• · Accounts receivable grew to $123,176 from $108,838 QoQ.
• · Litigation contingency remained steady at $17,000.
• · Agent growth incentive stock-based compensation expense $8,106 (up from prior periods implied).

11-05-2026

Elme Communities reports net assets in liquidation of $203,909 thousand as of March 31, 2026, down 14.6% from $238,915 thousand at December 31, 2025, amid ongoing liquidation with total assets declining 72.3% to $585,231 thousand and income producing property dropping 29.9% to $544,250 thousand; however, debt payable was reduced 35.1% to $337,492 thousand. Cash, cash equivalents, and restricted cash fell sharply 97.1% to $39,273 thousand, following the payout of a $1,303,723 thousand liquidating distribution. On a going concern basis for the three months ended March 31, 2025, the company recorded real estate rental revenue of $61,493 thousand but a net loss of $4,675 thousand.

• · Dividends declared $0.18 per common share for three months ended March 31, 2025
• · Net cash provided by operating activities $16,175 thousand for three months ended March 31, 2025
• · Net cash used in investing activities $5,698 thousand for three months ended March 31, 2025
• · Basic and diluted net loss per common share $(0.05) for three months ended March 31, 2025
• · Cash paid for interest $11,982 thousand for three months ended March 31, 2025

11-05-2026

Certara reported Q1 2026 revenues of $106.9M, nearly flat YoY at +0.9% from $106.0M, but swung to a net loss of $8.8M from a $4.7M profit due to sharply higher G&A expenses ($29.4M vs $19.7M) and operating loss of $4.3M vs prior profit. Cash from operations declined to $11.7M from $17.4M YoY while ending cash fell to $149.5M from $189.4M QoQ amid $40M share repurchases. Stockholders' equity decreased to $1.02B from $1.06B QoQ.

• · Goodwill decreased to $770.8M from $773.3M QoQ.
• · Intangible assets declined to $433.3M from $447.5M QoQ due to amortization.
• · Share repurchases totaled 5,814,484 shares for $40.4M in Q1 2026.
• · Capitalized software development costs $6.2M in Q1 2026, up from $5.2M YoY.

11-05-2026

Net sales rose 2.5% YoY to $99,369 in Q1 2026, with Professional (+12%) and DTC (+14%) channels growing while Specialty retail declined 13% YoY; US sales fell 3.5% but International increased 9%. However, operating expenses surged 30% to $76,771, primarily due to SG&A rising 37% to $65,951, resulting in an operating loss of $5,111 and net loss of $5,287 versus prior year profit. Cash from operations improved sharply to $7,499 from a $2,917 outflow.

• · Cash and cash equivalents increased QoQ to $326,169 from $318,731.
• · Total current assets decreased to $446,261 from $470,346 at year-end 2025.
• · Long-term debt stable at approximately $352M.

11-05-2026

Lexeo Therapeutics reported a narrowed net loss of $20,196 for the three months ended March 31, 2026, compared to $32,656 in the prior year period, driven by lower research and development expenses of $15,703 (down from $17,171) and sharply reduced general and administrative expenses of $6,630 (down from $16,634). However, the company continues to generate operating losses with total operating expenses of $22,333 and cash used in operations of $21,144, resulting in total assets declining to $250,356 from $268,688 at December 31, 2025, and stockholders' equity decreasing to $231,497.

• · Weighted-average shares outstanding increased to 81,183,812 in Q1 2026 from 33,113,991 in Q1 2025.
• · Net cash provided by investing activities was $27,460 in Q1 2026, primarily from investment maturities.
• · Investments in U.S. Treasury securities totaled $155,785 as of March 31, 2026 (Level 2 fair value).

11-05-2026

Apollo Debt Solutions BDC's total assets grew 4% QoQ to $26.9B as of March 31, 2026, with investments at fair value increasing 3% to $25.1B and cash rising 30% to $649M; investment income surged 43% YoY to $562M in Q1 2026, driving net investment income up 32% to $295M. However, elevated interest and debt expenses (+73% YoY to $159M) and substantial net unrealized losses of $309M contributed to a sharp 93% YoY decline in net increase in net assets to just $11M, while net assets fell 2% QoQ to $14.4B and NAV per share dropped 2% to $23.90.

• · Debt issuances of $2.1B offset by $1.0B repayments in Q1 2026, increasing net debt 11% QoQ.
• · Share repurchases net $696M in Q1 2026, with proceeds from new issuances of $592M.
• · Net cash used in operating activities $535M in Q1 2026, improved from $2.5B used in Q1 2025.
• · Unrealized depreciation on non-controlled/non-affiliated investments of $379M in Q1 2026.

11-05-2026

Bitfarms Ltd reported Q1 2026 revenues of $36,992, down 22% YoY from $47,651, leading to a gross loss of $26,305 versus a $276 profit in Q1 2025 amid higher cost of revenues. Net loss widened to $145,353 from $55,553 YoY, with operating loss deteriorating to $98,388 from $34,841, while total assets fell 18% QoQ to $1,066,711 and cash dropped 38% to $357,277. Stockholders' equity declined 25% QoQ to $419,135 despite debt reduction through $113,466 repayments.

• · Cash flows from operations worsened to $(64,687) from $(18,841) YoY.
• · Loss from discontinued operations $(17,779) similar to $(17,180) YoY.
• · Property, plant and equipment net $348,604, down from $358,333 QoQ.
• · Long-term debt stable at $573,203 vs $572,447 QoQ.

11-05-2026

Emerald Holding, Inc. reported Q1 2026 revenue of $155.4M, up 5.2% YoY from $147.7M. However, operating income fell 45.5% to $19.5M from $35.8M, driven by a 32.9% increase in SG&A expenses to $71.9M, leading to net income of $7.2M, down 52.9% from $15.3M. Positively, operating cash flow rose to $28.7M from $12.6M, and cash and equivalents increased to $121.1M.

• · Total assets increased to $1,243.6M as of March 31, 2026 from $1,212.8M as of December 31, 2025.
• · Stockholders’ equity slightly declined to $338.4M from $338.8M QoQ.
• · Basic weighted average common shares outstanding: 197,811 thousand in Q1 2026 vs. 200,596 thousand in Q1 2025.

11-05-2026

Village Farms International, Inc. reported Q1 2026 sales of $50,238 up 26.6% YoY from $39,680, with strong growth in International Exports (to $14,581, +170.6%) and Netherlands Branded ($2,663, +447.7%), though Canadian Non-Branded fell to $5,377 (-14.4%) and U.S. Cannabis to $3,133 (-19.7%). Gross profit surged 48.0% to $20,986, driving net income attributable to shareholders of $2,917 versus a $6,703 loss in Q1 2025; however, net cash used in operations worsened to $16,763 from $3,767, cash and equivalents dropped 37.8% QoQ to $50,468, and total assets declined 5.3% QoQ to $400,884.

• · Share repurchases of 2,065,000 shares for $6,368 during Q1 2026.
• · Property, plant and equipment increased to $189,560 from $185,712 QoQ.
• · Inventories rose to $44,420 from $41,519 QoQ, with finished goods cannabis up to $22,069.
• · Weighted average basic shares: 115,257 thousand in Q1 2026 vs 112,337 thousand in Q1 2025.
• · Comprehensive loss attributable to shareholders: $(455) in Q1 2026 vs $(5,811) in Q1 2025.

11-05-2026

ARKO Petroleum Corp. reported Q1 2026 total revenues of $1,344.4M, down 0.2% YoY to nearly flat, with fuel revenue up 6.7% to $807.6M offset by a 10.4% decline in related party fuel revenue to $514.5M. Net income increased 78.3% YoY to $8.1M and operating income rose 27.1% to $20.1M; however, net cash from operating activities dropped 56.1% to $6.6M amid a $70.9M increase in trade receivables. The company completed an IPO with $210.4M net proceeds, primarily repaying $209.4M long-term debt and reducing total debt over 50% QoQ to $184.5M.

• · Excise tax included in fuel revenue: $141.1M (non-related party) and $99.6M (related party) in Q1 2026
• · Trade receivables increased $70.9M QoQ to $151.5M
• · Cash and cash equivalents rose to $21.7M from $15.6M QoQ

11-05-2026

Liquidia Corporation reported robust Q1 2026 financial results with total revenue surging to $132,865 from $3,120 YoY, driven by $129,881 in product sales (vs. $0), resulting in net income of $52,862 compared to a $38,367 loss, and operating cash flow of $52,990 vs. negative $30,679. However, service revenue declined 4% to $2,984, R&D expenses rose 80% to $12,571, and SG&A increased 56% to $46,938. Cash and equivalents grew QoQ to $222,786 from $190,680, boosting stockholders' equity to $108,579 from $44,748.

• · Customer A represented 47% of gross product sales and 47% of accounts receivable as of March 31, 2026.
• · Customer B represented 39% of gross product sales and 46% of accounts receivable as of March 31, 2026.
• · Operating cash flow was $52,990 in Q1 2026 vs. ($30,679) in Q1 2025.
• · Net cash used in investing activities was $2,830 in Q1 2026 (vs. $330 in Q1 2025).
• · Basic EPS was $0.60 in Q1 2026 (vs. ($0.45) in Q1 2025).

11-05-2026

Perpetua Resources Corp. reported a net loss of $48,627 for the three months ended March 31, 2026, a sharp increase from $8,205 in the prior year period, primarily due to exploration and pre-development expenses rising to $53,098 from $13,094. Cash and cash equivalents declined to $669,505 from $714,171 quarter-over-quarter, while total assets fell to $854,721 from $877,644; however, buildings and equipment net increased significantly to $25,772 from $1,838, reflecting investing activity. The company outlined plans to complete approximately $2.7 billion in project financing, including a proposed senior secured loan from U.S. EXIM.

• · Net cash used in operating activities: $27,036 in Q1 2026 vs $25,644 in Q1 2025
• · Purchase of buildings and equipment: $19,355 in Q1 2026
• · Weighted average common shares outstanding increased to 124,694,794 from 70,619,291 YoY
• · Share-based compensation: $1,755 in Q1 2026

11-05-2026

FS KKR Capital Corp reported a net decrease in net assets from operations of $441M for Q1 2026, compared to a $120M increase in Q1 2025, driven by a 24% YoY decline in total investment income to $304M and a net realized and unrealized loss of $558M versus $67M loss prior year. NAV per share fell 9.9% QoQ to $18.83 from $20.89, with total investments declining 5.6% QoQ to $12,269M; however, operating expenses decreased 12% YoY to $187M and operating cash flow turned positive at $245M versus ($418M). Stockholder distributions were $134M, down from $196M YoY.

• · Debt net of deferred financing costs: $7,271M (Mar 2026) vs $7,634M (Dec 2025)
• · Interest expense: $105M (Q1 2026) vs $113M (Q1 2025)
• · Net realized loss on investments: $195M (Q1 2026) vs $18M gain (Q1 2025)
• · Purchases of investments: $505M (Q1 2026) vs $1,704M (Q1 2025)
• · Proceeds from sales/repayments: $760M (Q1 2026) vs $1,113M (Q1 2025)

11-05-2026

Dyne Therapeutics reported a Q1 2026 net loss of $120,854 thousand, up 4.7% YoY from $115,361 thousand, primarily due to a 53.2% surge in general and administrative expenses to $24,387 thousand despite a 5.2% decline in research and development expenses to $100,889 thousand. Cash used in operating activities increased 36.9% YoY to $144,922 thousand, driving a sharp $140,250 thousand net decrease in cash, cash equivalents, and restricted cash, with ending cash and equivalents at $753,102 thousand versus $893,369 thousand at December 31, 2025. However, interest income rose 23.3% YoY to $8,757 thousand, and net loss per share improved to ($0.73) from ($1.05) due to higher share count.

• · Weighted average common shares outstanding increased to 165,036,604 in Q1 2026 from 109,911,628 in Q1 2025.
• · Stock-based compensation expense was $13,081 thousand in Q1 2026, up slightly from $13,020 thousand in Q1 2025.
• · Long-term debt, net remained stable at $149,375 thousand as of March 31, 2026 versus $148,921 thousand at December 31, 2025.
• · Marketable securities slightly increased to $219,054 thousand as of March 31, 2026 from $217,193 thousand at December 31, 2025.

11-05-2026

For Q1 2026, Abacus Global Management reported total revenues of $59.4M, up 35% YoY from $44.1M, driven by a surge in life solutions related party revenue to $16.6M from $0.9M, leading to net income attributable to the company of $7.3M, up 57% YoY. However, operating income declined 13% YoY to $18.3M from $21.0M due to sharply higher G&A expenses ($25.9M vs $12.3M), total assets fell 8% QoQ to $829.8M from $902.2M, and life settlement policies at fair value dropped 16% QoQ to $392.8M. Operating cash flow swung to a strong $91.7M provided from $61.6M used YoY, supported by debt repayments of $77.9M and $14.5M in common stock repurchases.

• · Current portion of long-term debt at fair value reduced to $0 from $114.4M QoQ.
• · Treasury stock increased to $70.3M from $55.8M due to repurchases.
• · Stock-based compensation expense $6.3M in Q1 2026 vs $2.4M YoY.
• · Unrealized loss on policies at fair value $35.2M in Q1 2026 vs unrealized gain $27.0M YoY.
• · Interest expense $10.5M in Q1 2026, up from $9.6M YoY.
• · Series A convertible preferred stock $5.0M outstanding, with $93,750 dividend paid.

11-05-2026

Apogee Therapeutics reported a larger net loss of $74.1M for Q1 2026 compared to $55.3M in Q1 2025, driven by R&D expenses rising 31% to $60.8M and G&A up 31% to $22.0M, reflecting increased investment in development. However, the company significantly bolstered its cash position to $451.8M (up from $131.5M at year-end 2025) and total assets to $1.3B through $411.2M in net financing proceeds from equity offerings. Total stockholders' equity grew to $1.26B, providing a strong liquidity runway despite higher cash burn of $55.6M in operations.

• · Equity-based compensation expense increased to $17.2M in Q1 2026 from $11.1M in Q1 2025.
• · Unrealized loss on marketable securities of $1.8M in Q1 2026, vs gain of $0.2M in Q1 2025.
• · Net cash used in investing activities of $35.3M in Q1 35.Q1 2026, compared to provided $13.0M in Q1 2025.
• · Property and equipment, net slightly declined to $5.3M from $5.7M QoQ.

11-05-2026

Cronos Group reported strong YoY growth in net revenue to $45.2M (up 40% from $32.3M in Q1 2025) and net income attributable to Cronos of $13.8M (up 125% from $6.1M), driven by higher gross profit and other income including foreign currency gains. However, the company posted an operating loss of $1.8M (improved from $4.1M but still negative), comprehensive loss of $3.3M attributable to Cronos due to a $17.1M foreign exchange translation loss, and total assets declined 2% QoQ to $1.17B amid share repurchases reducing shares outstanding by 1.4% QoQ.

• · Net cash provided by operating activities $10.9M in Q1 2026 vs net cash used $2.1M in Q1 2025.
• · Net cash provided by investing activities $38.0M in Q1 2026 (due to short-term investment proceeds) vs net cash used $55.4M in Q1 2025.
• · Basic and diluted net income per share $0.04 in Q1 2026 vs $0.02 in Q1 2025.

11-05-2026

Intellia Therapeutics reported Q1 2026 collaboration revenue of $15M, down 9.5% YoY from $17M, amid a 25.6% reduction in R&D expenses to $81M but a 20.1% rise in G&A to $35M, resulting in total operating expenses of $116M (down 15.9% YoY) and a narrower net loss of $96M (15.8% improvement YoY) versus $114M. Cash and equivalents declined 13.3% QoQ to $135M from $155M, with net cash used in operations improving to $117M from $149M YoY, supported by $34M from at-the-market stock issuance. Total assets stood at $759M, down 9.9% QoQ, with stockholders' equity at $621M.

• · Weighted average shares outstanding Q1 2026: 118,490 thousand vs 103,500 thousand Q1 2025.
• · Investment in Kyverna Therapeutics, Inc. at $10M as of March 31, 2026 (down from $11M at Dec 31, 2025).
• · Deferred revenue declined to $0.6M from $7.3M QoQ.
• · Net cash provided by investing activities: $66M Q1 2026 vs $94M Q1 2025.

11-05-2026

AMERICAN BATTERY TECHNOLOGY Co reported robust revenue growth of 697% YoY to $7,811,229 for the three months ended March 31, 2026, with gross margin turning positive at $737,749 versus a $2,689,960 loss prior year, and cash balance surging to $37,685,027 from $7,474,304 as of June 30, 2025. However, net loss widened significantly to $33,836,197 in Q3 (from $11,495,947) and $53,416,735 for nine months (from $36,591,022), driven by soaring G&A expenses of $29,841,644 in Q3 largely from $33,143,776 stock-based compensation over nine months. Total assets expanded 41% to $119,428,228, supported by $55,353,778 in financing inflows, though operating cash use remained high at $19,616,904 for nine months.

• · Property and equipment, net increased to $55,231,160 from $45,469,853.
• · Restricted cash decreased to $800,000 from $5,000,000.
• · Shares outstanding grew to 132,271,860 from 97,398,519, reflecting issuances via ATM offerings, warrant exercises, and vesting.
• · Gross margin for nine months remained negative at $(4,378,270) but improved from $(8,003,944) prior year.

11-05-2026

International Money Express, Inc. (IMXI) reported Q1 2026 total revenues of $121,952, down 15.6% YoY from $144,310, driven by declines in wire transfer and money order fees (-17.0% to $99,752) and foreign exchange gains (-19.1% to $16,320), though other income rose 48.4% to $5,880. Operating expenses fell 9.2% YoY to $118,278, but operating income dropped 73.9% to $3,674 and net income plummeted 93.4% to $511 (EPS $0.02 vs $0.25). Total assets grew 9.4% QoQ to $565,942 while stockholders' equity edged up to $162,692, but long-term debt rose to $240,814 from $194,825.

• · Net cash used in operating activities was $37,364 in Q1 2026 vs provided by $41,282 YoY.
• · Interest expense decreased to $2,208 from $2,700 YoY.
• · Prepaid wires, net increased to $106,532 from $59,497 QoQ.

11-05-2026

CF Bankshares Inc. reported net income of $5,024 thousand for Q1 2026, up 13% YoY from $4,430 thousand, driven by a 3% increase in net interest income to $13,320 thousand and 23% growth in noninterest income to $1,487 thousand, while noninterest expenses rose 4% to $8,311 thousand. Total assets grew 1% QoQ to $2,145,776 thousand with loans up 1% to $1,761,262 thousand and deposits up 2% to $1,809,442 thousand; however, noninterest-bearing deposits declined 16% QoQ to $240,645 thousand and total interest income fell 4% YoY to $28,130 thousand. Earnings per share increased to $0.77 from $0.68 YoY.

• · Provision for credit losses increased to $604 thousand from $582 thousand YoY.
• · Stockholders' equity grew 3% QoQ to $188,955 thousand.
• · Cash dividends declared on common stock at $0.09 per share (up from $0.07 YoY).
• · Other comprehensive loss of $118 thousand in Q1 2026 vs income of $78 thousand in Q1 2025.

11-05-2026

BioScience Health Innovations, Inc. (BHIC) reported Q1 2026 revenues of $750,946, down 38.8% YoY from $1,227,070, leading to a gross profit decline of 45.8% to $485,596 and a net loss of $(229,907) versus net income of $426,798 in Q1 2025, driven by sharply higher operating expenses of $715,503 (up 52.5% YoY). However, cash and cash equivalents rose 73.0% QoQ to $1,145,005 from $661,925, bolstered by $1,035,187 in financing inflows including $437,067 from common stock sales, while total assets increased 36.6% QoQ to $2,330,239 and stockholders' equity grew 13.9% to $1,684,490. Operating cash flow swung to a use of $552,107 from prior-year provision of $328,309 amid inventory buildup.

• · Accounts receivable decreased 80.4% QoQ to $78,278 from $399,257.
• · Inventory increased 160.0% QoQ to $874,340 from $336,348.
• · Weighted average common shares basic decreased to 11,376,802 from 43,916,221 YoY.

11-05-2026

Hills Bancorporation reported Q1 2026 net income of $21,943 thousand, up 52% YoY from $14,433 thousand, fueled by net interest income growth of 22% to $41,793 thousand and a $1,066 thousand credit loss benefit versus a $3,870 thousand expense. Total assets reached $4,673,059 thousand, up 0.5% QoQ, with deposits increasing 6.9% to $3,599,618 thousand. However, noninterest expenses rose 16% YoY to $23,880 thousand, trust fees declined 2% to $3,966 thousand, and comprehensive income fell slightly to $15,033 thousand due to $6,910 thousand net unrealized securities losses.

• · Basic and diluted EPS $2.50 in Q1 2026 vs $1.61 in Q1 2025.
• · Purchased 37,094 shares of common stock in Q1 2026 for $3,130 thousand.
• · Cash dividends $1.23 per share in Q1 2026 vs $1.15 in Q1 2025.
• · Net cash from operating activities $21,153 thousand in Q1 2026 vs $15,046 thousand in Q1 2025.

11-05-2026

Owens & Minor reported Q1 2026 net revenue of $627,780 thousand, down 6.8% YoY from $673,884 thousand, driven by declines in most segments such as Sleep therapy (-8.2%), Home respiratory therapy (-10.5%), Wound care (-15.5%), and Other (-20.1%), though Ostomy (+3.7%) and Urology (+5.9%) showed growth. Operating income decreased 13.4% to $17,125 thousand amid higher interest expense, leading to a net loss from continuing operations of $6,468 thousand, wider than the prior year's $3,810 thousand loss but improved overall net loss excluding discontinued operations. Cash and equivalents increased to $336,880 thousand, supported by $96,415 thousand in proceeds from patient service equipment sales.

• · Cash used for operating activities worsened to $50,077 thousand from $35,066 thousand YoY.
• · Commercial payors revenue declined to $493,206 thousand from $543,528 thousand; Medicaid down to $8,859 thousand from $10,026 thousand.
• · Total current liabilities increased to $1,203,104 thousand from $947,075 thousand at Dec 31, 2025, driven by higher current debt.
• · Interest paid $29,446 thousand in Q1 2026 vs $27,487 thousand in Q1 2025.

11-05-2026

Esquire Financial Holdings, Inc. reported Q1 2026 net income of $12,211 thousand, up 7.0% YoY from $11,407 thousand, supported by net interest income growth of 23.2% to $34,004 thousand and noninterest income up 5.0% to $6,455 thousand. Total assets increased 2.4% QoQ to $2,421,155 thousand, with loans net of allowance up 3.3% to $1,791,550 thousand and deposits up 2.0% to $2,102,568 thousand. However, noninterest expenses rose 23.3% YoY to $20,657 thousand due to $1,272 thousand in merger expenses and higher employee compensation, provision for credit losses doubled to $2,700 thousand, cash equivalents declined 5.8% QoQ to $222,221 thousand, and other comprehensive loss of $960 thousand led to comprehensive income of $11,251 thousand down from $14,011 thousand YoY.

• · Diluted EPS $1.40 in Q1 2026, up from $1.33 YoY.
• · Basic EPS $1.48 in Q1 2026, up from $1.43 YoY.
• · Cash dividends declared $0.20 per share in Q1 2026 vs $0.175 in Q1 2025.
• · Stockholders’ equity $301,267 thousand as of March 31, 2026, up 4.0% QoQ.

11-05-2026

Quantum Computing Inc. reported Q1 2026 revenue of $3,691, a massive YoY increase from $39, driven by operational growth, alongside acquisitions of LSI ($97,499 cash + $2,038 equity) and NuCrypt ($2,433 cash). However, the company swung to a net loss of $4,050 from a $16,982 profit in Q1 2025, with operating loss widening to $20,550 from $8,286 due to higher expenses ($19,829 vs $8,299), and cash dropped sharply 65% QoQ to $257,711 from $737,880 amid heavy investing outflows of $474,253. Total assets remained stable at ~$1.62M, boosted by short-term investments ($728,401) and goodwill ($146,511).

• · Gross loss of $721 in Q1 2026 vs gross profit $13 in Q1 2025.
• · Net cash used in operating activities $9,423 in Q1 2026 vs $4,431 in Q1 2025.
• · Net cash used in investing activities $474,253 in Q1 2026 primarily from securities purchases ($710,658) offset by maturities ($316,859) and sales ($21,300), plus acquisitions.
• · Basic EPS $(0.02) in Q1 2026 vs $0.13 in Q1 2025.
• · Unrealized losses on available-for-sale debt securities $3,822 in Q1 2026.

11-05-2026

C&F Financial Corporation reported net income attributable to common shareholders of $6,747 thousand for Q1 2026, up 26% YoY from $5,368 thousand, with EPS of $2.08 versus $1.66; net interest income rose 11% YoY to $27,709 thousand while noninterest income increased 13% to $8,550 thousand. Total assets grew 1.6% QoQ to $2,813,748 thousand, driven by 2.3% higher deposits at $2,399,456 thousand and 1.0% loan growth to $2,035,387 thousand net. However, comprehensive income attributable fell to $5,336 thousand from $9,681 thousand due to a $1,411 thousand other comprehensive loss, provision for credit losses rose 20% YoY to $3,600 thousand, and operating cash flow used $7,572 thousand versus provided $3,211 thousand YoY.

• · Fair value measurements: Total securities AFS $470,619 thousand all Level 2; Rabbi trust assets $17,109 thousand Level 1.
• · Accumulated other comprehensive loss increased to $(12,577) thousand from $(11,166) thousand QoQ.
• · Shares repurchased: $614 thousand in Q1 2026 vs $426 thousand in Q1 2025.
• · Cash dividends declared: $0.48 per share ($1,560 thousand) in Q1 2026 vs $0.46 ($1,488 thousand) in Q1 2025.

11-05-2026

Tejon Ranch Co. (TRC) reported Q1 2026 total revenues of $9,503 up 15.8% YoY from $8,209, driven by mineral resources (+36.2% to $3,533) and new multifamily revenues ($696), with ranch operations up 24.1%; however, farming revenues declined 42.5% to $895 and commercial/industrial real estate was flat at $2,762. Operating loss narrowed to $1,131 from $4,166 YoY due to lower costs including corporate expenses down 55.4%, leading to net income of $151 versus a $1,466 loss prior year. Total assets grew slightly to $634,159 from $630,469 at year-end, though cash fell to $4,664 from $9,524.

• · Operating cash flow improved to $3,310 from ($1,345) YoY.
• · Investing cash used $8,865 vs $32,650 YoY.
• · Equity in earnings of unconsolidated joint ventures $1,290 (up from $1,158).
• · Real estate development includes $129,423 attributable to CFL at March 31, 2026.

11-05-2026

Constellation Energy reported strong Q1 2026 results with operating revenues surging 64% YoY to $11,122 million and net income attributable to common shareholders rising to $1,590 million from $118 million, reflecting robust performance amid higher energy realizations. The quarter included the completion of the Calpine acquisition, involving $17,507 million in common stock issuance and $2,537 million net cash outflow, significantly expanding the balance sheet to $96,911 million in total assets. However, operating cash flow was $425 million (up 297% YoY but modest relative to earnings), net cash decreased by $2,577 million due to heavy investing and financing activities, and debt levels rose sharply with short-term borrowings at $5,102 million and long-term debt at $16,994 million.

• · Capital expenditures of $1,275 million in Q1 2026, up from $806 million YoY.
• · Proceeds from short-term borrowings: $3,000 million; repayments: $1,500 million.
• · Issuance of long-term debt: $2,770 million; retirement: $5,254 million.
• · Assets held for sale increased to $5,735 million from $126 million QoQ.
• · Gain on sales of assets: $14 million.